A startup focusing on commercializing biological assays to detect hard-to-discern infectious diseases developed a test using Raman spectroscopy with the help of CCMR experts. Using the CCMR Raman and the expertise of a Cornell Materials scientist, the company tested the effects of varying conditions and morphology of their nanostructured metal surfaces and the resulting enhancement of the Raman signal produced in presence of the molecule of interest. To provide complementary services to businesses and enable commercialization of new products and technologies, CCMR has established a strong network of NY State organizations. Through this network, the company was introduced to a manufacturer enabling the company to produce a commercially viable prototype with consistent, signal detection and reproducibility, an important step towards pre-clinical studies and wide spread adoption of the technology.
Within a year of CCMR partnering the company with two Cornell fiber scientists in the College of Human Ecology, a startup originally from New York State was able to create the first prototype of a wearable ultrasonic pain therapy device. This innovative product—a disposable, adhesive patch implanted with a miniature ultrasonic device and a small amount of acoustic gel—caught the attention of venture capitalists. The company secured the FDA clearance and the funding to bring three wearable devices to market. They are being used in physical therapy and the fields of sports and veterinary medicine. The company now employs 24 people.
With the help of CCMR, a Rochester-based startup is turning its idea of a fertility test that the U.S. dairy industry can use to better manage herd breeding into a marketable product. Partnered with faculty members from Cornell’s biological engineering and materials science departments, the company has been able to optimize plant pigments-based diagnostic tests tracking mammals’ estrus cycles and to increase the shelf life of these tests. Subsequent field trials have allowed the company to obtain grant after grant to pursue the development of an affordable and single-use test that dairy farmers can use to track bovine estrus cycles, allowing better management of cow insemination and milk production. This innovation could save the dairy industry, the largest contributor to NY State agricultural economy, 25% in artificial insemination costs.